|
CAMK2D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.43440001280027E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.45780000293527E-08 |
| Normal-vs-Stage2 |
7.806000E-02 |
| Normal-vs-Stage3 |
1.73394999999354E-05 |
| Normal-vs-Stage4 |
4.056100000005E-05 |
| Stage1-vs-Stage2 |
8.775600E-02 |
| Stage1-vs-Stage3 |
7.873800E-01 |
| Stage1-vs-Stage4 |
5.874400E-01 |
| Stage2-vs-Stage3 |
1.770190E-01 |
| Stage2-vs-Stage4 |
8.790200E-02 |
| Stage3-vs-Stage4 |
4.962800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.99189999944483E-08 |
| Normal-vs-AfricanAmerican |
3.35590000011265E-07 |
| Normal-vs-Asian |
7.751300E-04 |
| Caucasian-vs-AfricanAmerican |
4.363400E-03 |
| Caucasian-vs-Asian |
9.263600E-01 |
| AfricanAmerican-vs-Asian |
1.478390E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.2049000000044E-05 |
| Normal-vs-Female |
4.0006999935116E-09 |
| Male-vs-Female |
2.493400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.12900000249061E-08 |
| Normal-vs-Age(41-60Yrs) |
5.19920000052743E-07 |
| Normal-vs-Age(61-80Yrs) |
3.015000E-04 |
| Normal-vs-Age(81-100Yrs) |
5.520000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.569800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.529200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.524150E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.806400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.144600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.094200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.133600E-02 |
| Classical-VS-Follicular |
2.121600E-02 |
| Classical-VS-Other |
4.324400E-01 |
| Classical-VS-Normal |
1.77750003604871E-09 |
| Tall-VS-Follicular |
3.502200E-03 |
| Tall-VS-Other |
9.481500E-02 |
| Tall-VS-Normal |
1.76289999997969E-06 |
| Follicular-VS-Other |
9.921800E-01 |
| Follicular-VS-Normal |
7.916800E-03 |
| Other-VS-Normal |
1.270220E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.54349999999371E-05 |
| Normal-vs-N1 |
1.122270E-03 |
| N0-vs-N1 |
5.420000E-01 |
|
|
